Trial Profile
The investigation of clinical effects of repaglinide in diabetic patients over 65 years old
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jul 2015
Price :
$35
*
At a glance
- Drugs Repaglinide (Primary)
- Indications Diabetes mellitus
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 23 May 2012 New trial record